Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Adenocarcinoma × Panitumumab × Clear all

Phase

Status

Completed 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 10 Esophageal Neoplasms 4 Neoplasms 3 Urinary Bladder Neoplasms 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Oesophago-gastric Cancer 1 KRAS and NRAS Wild-type Colorectal Cancer 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Cone Dystrophy 3 1 Colorectal Cancer Metastatic 1 Colonic Neoplasms 1 Breast Neoplasms 1 Advanced Colorectal Cancer 1 Adenocarcinoma Of Esophagus 1 Adenocarcinoma 1

Interventions

Gemcitabine 8 pembrolizumab 5 Carboplatin 5 Capecitabine 5 Pemetrexed 3 Oxaliplatin 3 Irinotecan 3 regorafenib 2 osimertinib 2 Taxes 2 Sunitinib 2 Radiotherapy 2 Paclitaxel 2 Fluorouracil 2 Cisplatin 2 130-nm albumin-bound paclitaxel 2 trifluridine tipiracil drug combination 1 tislelizumab 1 tegafur-gimeracil-oteracil 1 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1 sintilimab 1 seribantumab 1 selinexor 1 ruxolitinib 1 rubitecan 1 pralsetinib 1 palbociclib 1 olaparib 1 niraparib 1 linifanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00973193 2016-04-20

PrePaRad

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Phase 2 Terminated

Gastrointestinal

Adenocarcinoma, Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡